James S. Trippett

James S. Trippett

Auto-generated profile, based on publicly available information

James S. Trippett

Department of Bioengineering, Rice University, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHongyi R. Li
Hongyi R. Li
MHManwal Harb
Manwal Harb
JHJohn E. Heath
John E. Heath
JTJames S. Trippett
James S. Trippett
MSMikhail G. Shapiro
Mikhail G. Shapiro
JSJerzy O. Szablowski
Jerzy O. Szablowski
Targeted gene delivery to the brain is a critical tool for neuroscience research and has significant potential to treat human disease. However, the site-specific delivery of common gene vectors such as adeno-associated viruses (AAVs) is typically performed via invasive injections, which limit its applicable scope of research and clinical applications. Alternatively, focused ultrasound blood-brain-barrier opening (FUS-BBBO), performed noninvasively, enables the site-specific entry of AAVs into the brain from systemic circulation. However, when used in conjunction with natural AAV serotypes, this approach has limited transduction efficiency and results in substantial undesirable transduction of peripheral organs. Here, we use high throughput in vivo selection to engineer new AAV vectors specifically designed for local neuronal transduction at the site of FUS-BBBO. The resulting vectors substantially enhance ultrasound-targeted gene delivery and neuronal tropism while reducing peripheral transduction, providing a more than ten-fold improvement in targeting specificity in two tested mouse strains. In addition to enhancing the only known approach to noninvasively target gene delivery to specific brain regions, these results establish the ability of AAV vectors to be evolved for specific physical delivery mechanisms.

9 August 2024 in Science Advances
Verified
Journal Article
Open access
JSJoon Pyung Seo
Joon Pyung Seo
JTJames S. Trippett
James S. Trippett
ZHZhimin Huang
Zhimin Huang
SLSangsin Lee
Sangsin Lee
SNShirin Nouraein
Shirin Nouraein
JSJerzy O. Szablowski
Jerzy O. Szablowski
Gene expression is a critical component of brain physiology, but monitoring this expression in the living brain represents a major challenge. Here, we introduce a new paradigm called recovery of markers through insonation (REMIS) for noninvasive measurement of gene expression in the brain with cell type, spatial, and temporal specificity. Our approach relies on engineered protein markers that are produced in neurons but exit into the brain’s interstitium. When ultrasound is applied to targeted brain regions, it opens the blood-brain barrier and releases these markers into the bloodstream. Once in blood, the markers can be readily detected using biochemical techniques. REMIS can noninvasively confirm gene delivery and measure endogenous signaling in specific brain sites through a simple insonation and a subsequent blood test. REMIS is reliable and demonstrated consistent improvement in recovery of markers from the brain into the blood. Overall, this work establishes a noninvasive, spatially specific method of monitoring gene delivery and endogenous signaling in the brain.

27 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HLHongyi Li
Hongyi Li
JHJohn E. Heath
John E. Heath
JTJames S. Trippett
James S. Trippett
MSMikhail G. Shapiro
Mikhail G. Shapiro
JSJerzy O. Szablowski
Jerzy O. Szablowski
Targeted gene delivery to the brain is a critical tool for neuroscience research and has significant potential to treat human disease. However, the site-specific delivery of common gene vectors such as adeno-associated viruses (AAVs) is typically performed via invasive injections, limiting their scope of research and clinical applications. Alternatively, focused ultrasound blood-brain-barrier opening (FUS-BBBO), performed noninvasively, enables the site-specific entry of AAVs into the brain from systemic circulation. However, when used in conjunction with natural AAV serotypes, this approach has limited transduction efficiency, requires ultrasound parameters close to tissue damage limits, and results in undesirable transduction of peripheral organs. Here, we use high throughput in vivo selection to engineer new AAV vectors specifically designed for local neuronal transduction at the site of FUS-BBBO. The resulting vectors substantially enhance ultrasound-targeted gene delivery and neuronal tropism while reducing peripheral transduction, providing a more than ten-fold improvement in targeting specificity. In addition to enhancing the only known approach to noninvasively target gene delivery to specific brain regions, these results establish the ability of AAV vectors to be evolved for specific physical delivery mechanisms.

15 July 2025 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Open access
ACAnkush Chandra
Ankush Chandra
CECameron Ehsan
Cameron Ehsan
JTJames Trippett
James Trippett
MKMin J. Kim
Min J. Kim
MBMichael G. G Brandel
Michael G. G Brandel
MAManish K. Aghi
Manish K. Aghi
To identify applicant characteristics independently associated with matching into highly ranked U.S. neurosurgical residency programs. A retrospective cohort study analyzing American Association of Neurological Surgeons (AANS) data was conducted for U.S. medical graduates entering neurosurgical residencies from 2007 to 2017. Variables included demographics, medical school rank, region, advanced degrees, dedicated research years, publication count, and h-index. Primary outcome was matriculation into a "top" program, defined as (1) NIH Top 40 departments, (2) BRIMR Top 20 departments, and (3) Doximity Top 20 programs. Univariate testing was followed by multivariable logistic regression to determine independent predictors of matching into a top program. Among 1692 residents 82% male; mean age, 31.9 ± 7.9 yr), 26.7% graduated from a U.S. News top-25 medical school; median h-index was 1 (IQR 0-3) with 2 (IQR 0-4) publications; 78.5% took ≥ 1 research year, 8.4% held a PhD, and 1.4% were DO graduates. For NIH top-40 placement, independent predictors were graduating from a top-25 medical school (OR 3.43, 95% CI 2.61-4.50), higher h-index (OR per point 1.12, 1.07-1.17), PhD (OR 2.15, 1.39-3.33), and Master's/MPH degrees (OR 2.05-3.31). Gap years (OR 0.71, 0.55-0.92) and DO degrees (OR 0.06, 0.01-0.45) decreased odds. BRIMR and Doximity models showed comparable effects although older age unfavorably impacted BRIMR matches. Highly ranked neurosurgery residencies consistently favor graduates of highly ranked medical schools who demonstrate strong research productivity. Each incremental h-index point raises top program match likelihood by 12-18 %. In contrast, unproductive gap years and holding an osteopathic (DO) degree each independently predicted lower odds of matching to a top program. These benchmarks can guide applicants and mentors as residency selection evolves beyond numeric board scores.

24 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJoon Pyung Seo
Joon Pyung Seo
JTJames S. Trippett
James S. Trippett
ZHZhimin Huang
Zhimin Huang
RWRyan Z. Wang
Ryan Z. Wang
SLSangsin Lee
Sangsin Lee
JSJerzy O. Szablowski
Jerzy O. Szablowski
Gene expression is a critical component of brain physiology and activity, but monitoring this expression in the living brain represents a significant challenge. Here, we introduce a new paradigm called Recovery of Markers through InSonation (REMIS) for noninvasive measurement of gene expression in the brain with cell-type, spatial, and temporal specificity. Our approach relies on engineered protein markers that are designed to be expressed in neurons and exit into the interstitium. By applying ultrasound to targeted brain regions, these markers are released into the bloodstream, where they can be readily detected using biochemical techniques. REMIS can noninvasively confirm gene delivery and measure endogenous signaling in specific brain sites through a simple insonation and a subsequent blood test. Using REMIS, we successfully measured chemogenetic induction of neuronal activity in ultrasound-tar-geted brain regions. REMIS recovery of markers is reliable and demonstrated improved recovery of markers from the brain into the blood in every tested animal. Overall, our work establishes a noninvasive, spatially-specific means of monitoring gene delivery outcomes and endogenous signaling in mammalian brains, opening up possibilities for brain research and noninvasive monitoring of gene therapies in the brain.

15 October 2025 in World Neurosurgery
Verified
Journal Article
Open access
ACAnkush Chandra
Ankush Chandra
AHAlexander Hayes
Alexander Hayes
CECameron Ehsan
Cameron Ehsan
LZLaura Zima
Laura Zima
JTJames Trippett
James Trippett
MAManish Aghi
Manish Aghi
Neurosurgery is one of the most competitive residencies with only a small number of Doctor of Osteopathy (DO) graduates matching each year. This study aims to identify applicant characteristics associated with successful neurosurgery match among DOs. We conducted a retrospective analysis of DO graduates who matched into neurosurgery from 2007-2017. Data on demographics, research productivity, gap years, program accreditation, fellowship training, and current practice setting were obtained from the American Association of Neurological Surgeons and public sources. Multivariate logistic regression identified independent predictors of matching into Accreditation Council for Graduate Medical Education (ACGME)-accredited programs. Of 1883 US neurosurgery matriculants, 111 (6%) were DO graduates. Of these, only 18 (16%) entered ACGME programs. Compared to their peers in American Osteopathic Association programs, ACGME-matched DOs had a significantly higher number of preresidency publications (median 4 vs. 1, P < 0.001) and H-indices (median 2 vs. 0, P < 0.001). They were also more likely to have completed a research gap year and pursue fellowship training and academic practice (P < 0.05). Independent predictors of ACGME match included gap year completion (odds ratio [OR]: 5.96; 95% confidence interval [CI]: 1.40-25.3), number of publications (OR: 1.86; 95% CI: 1.17-2.94), and older age (OR: 1.22; 95% CI: 1.01-1.47). The osteopathic institutions with the highest number of neurosurgery matches were geographically clustered near metropolitan research hubs. For DO applicants, taking a research-focused gap year and demonstrating strong scholarly output significantly increase the likelihood of ACGME match. Implementing targeted mentorship and research programs at osteopathic medical schools may help bridge the gap in research productivity and enhance DO match success in neurosurgery.